DESCRIPTION OF THE REAL-WORLD TREATMENT PATTERNS OF GUSELKUMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL DATASET

被引:0
|
作者
Littlejohn, G. [1 ,2 ]
Anbumurali, N. [1 ]
Bird, P. [1 ,3 ,4 ]
Youssef, P. [1 ,5 ,6 ]
Osullivan, C. [1 ]
Smith, T. [1 ]
Sumpton, D. [1 ,5 ,7 ]
Kane, B. [1 ,7 ]
Mcgeachie, A. [8 ]
Spiers, S. [9 ]
Deakin, C. [1 ]
机构
[1] OPAL Rheumatol Ltd, Rheumatol, Sydney, NSW, Australia
[2] Monash Univ, Dept Med, Clayton, Australia
[3] Univ New South Wales, Sch Clin Med, Kensington, Australia
[4] Emeritus Res, Rheumatol, Botany, Australia
[5] Univ Sydney, Dept Med, Sydney, Australia
[6] Royal Prince Alfred Hosp, Dept Rheumatol, Camperdown, Australia
[7] Concord Repatriat Gen Hosp, Dept Rheumatol, Concord, Australia
[8] Janssen, Outcomes Res, Macquarie, Australia
[9] Janssen, Med Affairs, Macquarie, Australia
关键词
Real-world evidence; Psoriatic arthritis; bDMARD;
D O I
10.1136/annrheumdis-2023-eular.3359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB1112
引用
收藏
页码:1785 / 1785
页数:1
相关论文
共 50 条
  • [41] Real-world Persistence and Treatment Patterns in Psoriatic Arthritis Patients Treated with Anti-IL17 Therapy
    Joven, Beatriz E.
    Fito Manteca, Concepcion
    Rubio, Enrique
    Raya Alvarez, Enrique
    Perez, Alba
    Hernandez, Raquel
    Arija, Sara Manrique
    Nunez, Mercedes
    Diaz, Silvia
    Trancho, Luis
    Moyano, Sebastian
    Lacetera, Alessandra
    Alfaro-Oliver, Noelia
    Garcia-Vicuna, Rosario
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4239 - 4241
  • [42] REAL-WORLD STUDY ON THE PATTERNS AND COST OF TREATMENT FAILURE IN PATIENTS WITH PSORIATIC ARTHRITIS USING US CLAIMS DATA
    Price, K.
    Alemao, E.
    Burns, L.
    Guo, Z.
    Anupindi, V.
    Goday, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 677 - 677
  • [43] Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study
    Dattola, A.
    Balato, A.
    Megna, M.
    Gisondi, P.
    Girolomoni, G.
    De Simone, C.
    Caldarola, G.
    Cama, E.
    Piaserico, S.
    Fargnoli, M. C.
    Fidanza, R.
    Parodi, A.
    Burlando, M.
    Offidani, A.
    Diotallevi, F.
    Potenza, C.
    Conti, A.
    Chiricozzi, A.
    Campione, E.
    Bianchi, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (12) : 2839 - 2845
  • [44] Real-world Management of CML: Outcomes and Treatment Patterns
    Nicole Held
    Ehab L. Atallah
    Current Hematologic Malignancy Reports, 2023, 18 : 167 - 175
  • [45] Real-world Management of CML: Outcomes and Treatment Patterns
    Held, Nicole
    Atallah, Ehab L. L.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 167 - 175
  • [46] Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors
    Walsh, Jessica A.
    Lin, Iris
    Zhao, Ruizhi
    Shiff, Natalie J.
    Morrison, Laura
    Emond, Bruno
    Yu, Louise H.
    Schwartzbein, Samuel
    Lefebvre, Patrick
    Pilon, Dominic
    Chakravarty, Soumya D.
    Mease, Philip
    DRUGS-REAL WORLD OUTCOMES, 2024, 11 (03) : 487 - 499
  • [47] Real-world Utilisation and Switching Between Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in the Australian OPAL Dataset
    Ciciriello, Sabina
    Littlejohn, Geoffrey
    Treuer, Tamas
    Gibson, Kathryn
    Youssef, Peter
    Bird, Paul
    OSullivan, Catherine
    Smith, Tegan
    Deakin, Claire
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 521 - 522
  • [48] Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors
    Philip J. Mease
    Shannon A. Ferrante
    Natalie J. Shiff
    Timothy P. Fitzgerald
    Soumya D. Chakravarty
    Jessica A. Walsh
    Advances in Therapy, 2025, 42 (2) : 734 - 751
  • [49] REAL-WORLD UTILISATION AND SWITCHING BETWEEN JANUS KINASE INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE AUSTRALIAN OPAL DATASET
    Ciciriello, Sabina
    Littlejohn, Geoffrey
    Treuer, Tamas
    Gibson, Kathryn A.
    Youssef, Peter
    Bird, Paul
    O'Sullivan, Catherine
    Smith, Tegan
    Deakin, Claire T.
    Pile, Kevin
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 36 - 36
  • [50] Effectiveness and Safety of Infliximab in the Management of Psoriatic Arthritis: Real-World Data from the Biologic Treatment Registry Across Canada (BioTRAC)
    Rahman, Proton
    Choquette, Denis
    Chow, Andrew
    Kapur, Suneil
    Fortin, Isabelle
    Khraishi, Majed
    Zummer, Michel
    Baker, Milton
    Rampakakis, Emmanouil
    Osborne, Brendan
    Asin-Milan, Odalis
    Lehman, Allen
    Nantel, Francois
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 847 - 847